Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	7.52	-44.18	-47.77
Graham Fair Price	93.65	2639.11	1362.84
PEG	6120.37	0.13	< 0.005
Price/Book	-89.34	0.44	4.13
Price/Cash Flow	-75.99	-22.29	92.83
Prices/Earnings	-68.68	-6.63	-3.93
Price/Sales	-84.76	10.21	67.00
Price/FCF	-75.99	-22.29	92.83
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-70.91	0.06	-0.20
Operating Margin	57.17	-0.77	-1.79
ROA	93.86	-0.01	-0.16
ROE	-0.26	-0.02	93.68
ROIC	-0.07	< 0.005	91.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.27	-94.13
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.83	0.71	-61.55
EPS QOQ	-18.92	0.51	-97.29
FCF QOQ	2.15	-1.44	-33.18
Revenue QOQ	0.13	-0.31	144.91
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	159.00	314.90	98.05
Days Sales Outstanding (DSO)	103.86	129.20	24.40
Inventory Turnover	0.57	0.29	-49.51
Debt/Capitalization	0.31	0.31	2.62
Quick Ratio	0.23	0.19	-18.30
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	560.72	4318.58	670.18
Cash	15.29	113.99	645.56
Capex	33.94	-29.91	-11.85
Free Cash Flow	24.92	-85.24	242.06
Revenue	34.53	186.12	439.03
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.54	0.49	-8.14
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.83	-23.08	-378.35
Naive Interpretation	Member

06 - Financial Health · Bad

Rating